Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-07

Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of botulinum toxin type A for knee osteoarthritis pain; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-08-07